Pharmafile Logo
Pharmafocus logo
Advanced Search
janeg

J&J lines up its Global Head for Actelion

May 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Janssen, Johnson & Johnson

The deal is not yet complete but the last steps are assumed to be a formality – at least Johnson …

Appointment

Behind the NHS recruitment crisis

May 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, laid a stark warning at the door of the …

Feature
sanofi_new_paris_hq

Sanofi Zika vaccine deal causes controversy

May 22, 2017
Sales and Marketing Sanofi, US army, Zika

In a further twist to Sanofi’s deal with the US Army to develop a vaccine for the Zika virus, the …

News

Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones

May 22, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Novartis

Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …

News
amgen_hq

Amgen hit by major safety blow on osteoporosis drug

May 22, 2017
Research and Development, Sales and Marketing Amgen, Romosozumab, UCB SA

Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …

News

70 patients sue Pfizer over arthritis drug risks

May 22, 2017
Sales and Marketing Pfizer, celebrex

Pfizer has been hit with a £3.5 million lawsuit by 70 Scottish patients who claim that the use of its …

News
astrazeneca_logo_building

AstraZeneca sells off rights to beta-blocker for $300 million

May 22, 2017
Sales and Marketing AstraZeneca, Recordati, Seloken

AstraZeneca announced that it had sold the European rights to its drug, Seloken (metoprolol), to Italian pharmaceutical company Recordati. The …

News
melanoma

No causal link between Viagra use and melanoma, study finds

May 19, 2017
Medical Communications, Research and Development melanoma, viagra

Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …

News
abbviehqe_011_low

AbbVie suffers knock to Humira patent

May 19, 2017
Medical Communications, Sales and Marketing AbbVie, Humira, patents

Humira is the largest selling pharmaceutical drug in the world. The treatment for rheumatoid arthritis brought in over $16 billion …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

With every week we draw closer to the event everyone in the UK is talking about – the general election. …

News
gavel

J&J launches lawsuit to block release of Remicade biosimilar

May 19, 2017
Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis

Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …

News
shutterstock_57369385

Pharma’s Identity Crisis: Four strategies for creating value in life sciences

May 19, 2017
Medical Communications pharmafile

As the demands of healthcare across the world begin to rise, PwC outlines four strategies for creating value in life …

News
facilities_lg06

Dr Reddy’s gets greenlight to market Doxil generic

May 18, 2017
Sales and Marketing Dr Reddy's, FDA

Dr Reddy’s Laboratories, one of India’s largest pharmaceutical firms, has revealed that the FDA has given the go-ahead to market …

News
lungs

Off-patent cancer drug holds promise for severe asthma treatment

May 18, 2017
Research and Development asthma, imatinib

Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …

News

FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years

May 18, 2017
Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als

The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …

News
pills-384846_960_720

Research suggests opioid crisis stems from prescription approach

May 18, 2017
Medical Communications, Research and Development opioid crisis, opioids

The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …

News
sicorbio

500 staff face the axe as Teva cans Hungary plant

May 18, 2017
Manufacturing and Production Teva

Israeli pharmaceutical firm Teva has announced that it plans to cease operations at a manufacturing plant in Gödöllő in Budapest, …

News
astrazeneca_building_white

AZ launches lawsuit against former executive for defecting to GSK

May 17, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline

AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …

News

Bayer celebrates FDA priority review for investigational blood cancer drug

May 17, 2017
Research and Development, Sales and Marketing Bayer, FDA, blood cancer

Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …

News

T cells found to ‘acquire knowledge’ to take fight to metastatic cancer

May 17, 2017
Research and Development Cancer, T cell, immunotherapy

T cells are widely known as being crucial in the fight against cancer within the body but little was known, …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026